Validation of the RECap of AtoPic eczema measure of eczema control for use in dermatology clinics

Alisha Bhanot, Rosie C Vincent, TJ Peters, Matthew J Ridd*

*Corresponding author for this work

Research output: Contribution to journalLetter (Academic Journal)peer-review

13 Downloads (Pure)

Abstract

The HOME (Harmonising Outcome Measures for Eczema) initiative seeks to standardise outcome measures in trials of eczema treatments.1 RECAP (Recap for atopic eczema) is a seven-item HOME recommended patient reported outcome measure of eczema control.2 The total score of RECAP is from 0 to 28, with a greater score indicating poorer eczema control. In an online survey of 382 participants, RECAP was found to have good validity and reliability.3 However, validity and reliability can vary by both population and setting.
Original languageEnglish
Pages (from-to)440-442
Number of pages3
JournalClinical and Experimental Dermatology
Volume47
Issue number2
Early online date23 Oct 2021
DOIs
Publication statusPublished - 1 Feb 2022

Fingerprint

Dive into the research topics of 'Validation of the RECap of AtoPic eczema measure of eczema control for use in dermatology clinics'. Together they form a unique fingerprint.

Cite this